Takeda and Innovent have closed their global partnership for next-generation IO and ADC therapies after fulfilment of ...

The strategic partnership sees two separate financial deals for the pair of oncology assets. Rights to Kelun’s integrin ...

By analyzing real-world data, digital health organizations can gain insights into actual costs, measure outcomes, and build ...

Opinions amongst the CDC's ACIP were divided on the continued use of the hepatitis B vaccine in a paediatric population.

Denali has entered a $275m royalty funding agreement with Royalty Pharma based on future net sales of tividenofusp alfa therapy.